查看購物車
  • Simplified Chinese
  • English
封面
市場調查報告書
商品編碼
1609833

2024-2032 年日本臨床試驗管理系統市場報告（按組件、部署模式、最終用戶和地區）

Japan Clinical Trials Management System Market Report by Component, Deployment Mode, End User, and Region 2024-2032
出版日期: | 出版商: IMARC | 英文 115 Pages | 商品交期: 5-7個工作天內

價格
簡介目錄

2023年日本臨床試驗管理系統市場IMARC Group達1.0638億美元。臨床試驗的複雜性日益普遍，涉及更大的資料集、多個研究地點和複雜的監管要求，加上對簡化試驗管理和確保合規性的系統解決方案的需求不斷成長，主要推動了市場的發展。

臨床試驗管理系統（CTMS）是一個全面的軟體解決方案，用於最佳化和簡化醫學研究領域臨床試驗的管理。它是研究人員、申辦者和研究協調員規劃、執行和監控臨床試驗各個方面的集中平台。 CTMS 促進高效的參與者招募、追蹤法規遵循、管理預算和資源，並產​​生即時報告以做出明智的決策。它還增強了利害關係人之間的溝通和協作，實現無縫資料共享和試驗活動記錄。 CTMS 的主要功能通常包括方案管理、病患登記和隨機化、就診安排、資料收集、不良事件追蹤和財務管理。這些系統對於確保資料準確性、方案遵守和法規遵循至關重要，最終加速藥物開發流程並提高病患安全。總之，CTMS 透過提供集中且有組織的試驗管理、資料收集和報告方法，從而推動醫學研究和醫療保健創新，在臨床試驗的成功執行中發揮關鍵作用。

日本臨床試驗管理系統市場趨勢：

在多種因素的推動下，日本的臨床試驗管理系統市場目前正經歷顯著成長。首先，臨床試驗日益複雜，需要先進的 CTMS 解決方案。因此，製藥和生技公司正在採用這些系統來簡化試驗流程，提高效率並降低營運成本。此外，臨床研究中對資料整合和即時分析的日益重視也刺激了 CTMS 的採用。因此，CTMS 解決方案可與電子健康記錄 (EHR) 和其他醫療資料來源無縫整合，促進試驗期間更好的數據驅動決策。此外，監管機構提出了嚴格的合規要求，使得組織必須保持準確和最新的試驗記錄。 CTMS 平台提供資料和文件的集中儲存庫，確保合規性並促進稽核。此外，臨床試驗的區域擴張和虛擬試驗的興起增加了對具有強大遠端監控和患者參與功能的系統的需求，預計將在預測期內推動日本臨床試驗管理系統市場的發展。

日本臨床試驗管理系統市場區隔：

組件見解：

  • 軟體
  • 服務

部署模式見解：

  • 網路為基礎的 CTMS
  • 本地
  • 基於雲端的CTMS

最終使用者見解：

  • 製藥和生物技術公司
  • 合約研究組織
  • 其他

競爭格局：

市場研究報告也對市場競爭格局進行了全面分析。報告涵蓋了市場結構、關鍵參與者定位、最佳制勝策略、競爭儀表板和公司評估象限等競爭分析。此外，也提供了所有主要公司的詳細資料。

本報告回答的關鍵問題：

  • 日本臨床試驗管理系統市場迄今表現如何，未來幾年將如何表現？
  • COVID-19 對日本臨床試驗管理系統市場有何影響？
  • 日本臨床試驗管理系統市場以組件分類是怎樣的？
  • 日本臨床試驗管理系統市場依部署模式分類是怎樣的？
  • 日本臨床試驗管理系統市場以最終用戶分類是怎樣的？
  • 日本臨床試驗管理系統市場價值鏈的各個階段是什麼？
  • 日本臨床試驗管理系統的關鍵促進因素與挑戰是什麼？
  • 日本臨床試驗管理系統市場的結構如何？
  • 日本臨床試驗管理系統市場的競爭程度如何？

本報告回答的關鍵問題：

  • 日本臨床試驗管理系統市場迄今表現如何，未來幾年將如何表現？
  • COVID-19 對日本臨床試驗管理系統市場有何影響？
  • 日本臨床試驗管理系統市場以組件分類是怎樣的？
  • 日本臨床試驗管理系統市場依部署模式分類是怎樣的？
  • 日本臨床試驗管理系統市場以最終用戶分類是怎樣的？
  • 日本臨床試驗管理系統市場價值鏈的各個階段是什麼？
  • 日本臨床試驗管理系統的關鍵促進因素與挑戰是什麼？
  • 日本臨床試驗管理系統市場的結構如何？
  • 日本臨床試驗管理系統市場的競爭程度如何？

目錄

第1章：前言

第 2 章：範圍與方法

  • 研究目的
  • 利害關係人
  • 數據來源
    • 主要來源
    • 二手資料
  • 市場預測
    • 自下而上的方法
    • 自上而下的方法
  • 預測方法

第 3 章：執行摘要

第 4 章：日本臨床試驗管理系統市場 - 簡介

  • 概述
  • 市場動態
  • 產業動態
  • 競爭情報

第 5 章：日本臨床試驗管理系統市場格局

  • 歷史與當前市場趨勢（2018-2023）
  • 市場預測（2024-2032）

第 6 章：日本臨床試驗管理系統市場 - 細分：按組成部分

  • 軟體
    • 概述
    • 歷史與當前市場趨勢（2018-2023）
    • 市場預測（2024-2032）
  • 服務
    • 概述
    • 歷史與當前市場趨勢（2018-2023）
    • 市場預測（2024-2032）

第 7 章：日本臨床試驗管理系統市場 - 細分：依部署模式

  • 網路為基礎的 CTMS
    • 概述
    • 歷史與當前市場趨勢（2018-2023）
    • 市場預測（2024-2032）
  • 本地
    • 概述
    • 歷史與當前市場趨勢（2018-2023）
    • 市場預測（2024-2032）
  • 基於雲端的CTMS
    • 概述
    • 歷史與當前市場趨勢（2018-2023）
    • 市場預測（2024-2032）

第 8 章：日本臨床試驗管理系統市場 - 細分：依最終使用者分類

  • 製藥和生物技術公司
    • 概述
    • 歷史與當前市場趨勢（2018-2023）
    • 市場預測（2024-2032）
  • 合約研究組織
    • 概述
    • 歷史與當前市場趨勢（2018-2023）
    • 市場預測（2024-2032）
  • 其他
    • 歷史與當前市場趨勢（2018-2023）
    • 市場預測（2024-2032）

第 9 章：日本臨床試驗管理系統市場 - 競爭格局

  • 概述
  • 市場結構
  • 市場參與者定位
  • 最佳制勝策略
  • 競爭儀表板
  • 公司評估象限

第 10 章：關鍵參與者簡介

  • Company A
    • Business Overview
    • Product Portfolio
    • Business Strategies
    • SWOT Analysis
    • Major News and Events
  • Company B
    • Business Overview
    • Product Portfolio
    • Business Strategies
    • SWOT Analysis
    • Major News and Events
  • Company C
    • Business Overview
    • Product Portfolio
    • Business Strategies
    • SWOT Analysis
    • Major News and Events
  • Company D
    • Business Overview
    • Product Portfolio
    • Business Strategies
    • SWOT Analysis
    • Major News and Events
  • Company E
    • Business Overview
    • Product Portfolio
    • Business Strategies
    • SWOT Analysis
    • Major News and Events

第 11 章：日本臨床試驗管理系統市場 - 產業分析

  • 促進因素、限制因素和機會
    • 概述
    • 促進要素
    • 限制
    • 機會
  • 波特五力分析
    • 概述
    • 買家的議價能力
    • 供應商的議價能力
    • 競爭程度
    • 新進入者的威脅
    • 替代品的威脅
  • 價值鏈分析

第 12 章：附錄

簡介目錄
Product Code: SR112024A18014

Japan clinical trials management system market size reached US$ 106.38 Million in 2023. Looking forward, IMARC Group expects the market to reach US$ 244.74 Million by 2032, exhibiting a growth rate (CAGR) of 9.10% during 2024-2032. The increasing prevalence of clinical trial complexity, involving larger datasets, multiple study sites, and intricate regulatory requirements, coupled with the rising need for system solutions to streamline trial management and ensure compliance, is primarily driving the market.

A clinical trials management system (CTMS) is a comprehensive software solution to optimize and streamline the management of clinical trials in the field of medical research. It serves as a centralized platform for researchers, sponsors, and study coordinators to plan, execute, and monitor all aspects of a clinical trial. CTMS facilitates efficient participant recruitment, tracks regulatory compliance, manages budgets and resources, and generates real-time reports for informed decision-making. It also enhances communication and collaboration among stakeholders, enabling seamless data sharing and documentation of trial activities. Key features of a CTMS typically include protocol management, patient enrollment and randomization, visit scheduling, data capture, adverse event tracking, and financial management. These systems are vital in ensuring data accuracy, protocol adherence, and regulatory compliance, ultimately accelerating the drug development process and improving patient safety. In summary, a CTMS plays a pivotal role in the successful execution of clinical trials by offering a centralized and organized approach to trial management, data collection, and reporting, thereby advancing medical research and healthcare innovation.

Japan Clinical Trials Management System Market Trends:

The clinical trials management system market in Japan is currently experiencing significant growth, driven by a combination of factors. Firstly, the increasing complexity of clinical trials necessitates advanced CTMS solutions. Consequently, pharmaceutical and biotechnology companies are adopting these systems to streamline their trial processes, enhancing efficiency and reducing operational costs. Furthermore, the growing emphasis on data integration and real-time analytics in clinical research has spurred CTMS adoption. As a result, CTMS solutions offer seamless integration with Electronic Health Records (EHRs) and other healthcare data sources, promoting better data-driven decision-making during trials. Moreover, regulatory agencies have imposed stringent compliance requirements, making it imperative for organizations to maintain accurate and up-to-date trial records. CTMS platforms provide a centralized repository for data and documentation, ensuring regulatory compliance and facilitating audits. Additionally, the regional expansion of clinical trials and the rise of virtual trials, which have increased the demand for systems with robust remote monitoring and patient engagement capabilities, is expected to drive the clinical trials management system market in Japan during the forecast period.

Japan Clinical Trials Management System Market Segmentation:

Component Insights:

  • Software
  • Services

Deployment Mode Insights:

  • Web-based CTMS
  • On-premises
  • Cloud-based CTMS

End User Insights:

  • Pharmaceutical and Biotechnology Firms
  • Contract Research Organizations
  • Others

Competitive Landscape:

The market research report has also provided a comprehensive analysis of the competitive landscape in the market. Competitive analysis such as market structure, key player positioning, top winning strategies, competitive dashboard, and company evaluation quadrant has been covered in the report. Also, detailed profiles of all major companies have been provided.

Key Questions Answered in This Report:

  • How has the Japan clinical trials management system market performed so far and how will it perform in the coming years?
  • What has been the impact of COVID-19 on the Japan clinical trials management system market?
  • What is the breakup of the Japan clinical trials management system market on the basis of component?
  • What is the breakup of the Japan clinical trials management system market on the basis of deployment mode?
  • What is the breakup of the Japan clinical trials management system market on the basis of end user?
  • What are the various stages in the value chain of the Japan clinical trials management system market?
  • What are the key driving factors and challenges in the Japan clinical trials management system?
  • What is the structure of the Japan clinical trials management system market and who are the key players?
  • What is the degree of competition in the Japan clinical trials management system market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Japan Clinical Trials Management System Market - Introduction

  • 4.1 Overview
  • 4.2 Market Dynamics
  • 4.3 Industry Trends
  • 4.4 Competitive Intelligence

5 Japan Clinical trials management system Market Landscape

  • 5.1 Historical and Current Market Trends (2018-2023)
  • 5.2 Market Forecast (2024-2032)

6 Japan Clinical Trials Management System Market - Breakup by Component

  • 6.1 Software
    • 6.1.1 Overview
    • 6.1.2 Historical and Current Market Trends (2018-2023)
    • 6.1.3 Market Forecast (2024-2032)
  • 6.2 Services
    • 6.2.1 Overview
    • 6.2.2 Historical and Current Market Trends (2018-2023)
    • 6.2.3 Market Forecast (2024-2032)

7 Japan Clinical Trials Management System Market - Breakup by Deployment Mode

  • 7.1 Web-based CTMS
    • 7.1.1 Overview
    • 7.1.2 Historical and Current Market Trends (2018-2023)
    • 7.1.3 Market Forecast (2024-2032)
  • 7.2 On-premises
    • 7.2.1 Overview
    • 7.2.2 Historical and Current Market Trends (2018-2023)
    • 7.2.3 Market Forecast (2024-2032)
  • 7.3 Cloud-based CTMS
    • 7.3.1 Overview
    • 7.3.2 Historical and Current Market Trends (2018-2023)
    • 7.3.3 Market Forecast (2024-2032)

8 Japan Clinical Trials Management System Market - Breakup by End User

  • 8.1 Pharmaceutical and Biotechnology Firms
    • 8.1.1 Overview
    • 8.1.2 Historical and Current Market Trends (2018-2023)
    • 8.1.3 Market Forecast (2024-2032)
  • 8.2 Contract Research Organizations
    • 8.2.1 Overview
    • 8.2.2 Historical and Current Market Trends (2018-2023)
    • 8.2.3 Market Forecast (2024-2032)
  • 8.3 Others
    • 8.3.1 Historical and Current Market Trends (2018-2023)
    • 8.3.2 Market Forecast (2024-2032)

9 Japan Clinical Trials Management System Market - Competitive Landscape

  • 9.1 Overview
  • 9.2 Market Structure
  • 9.3 Market Player Positioning
  • 9.4 Top Winning Strategies
  • 9.5 Competitive Dashboard
  • 9.6 Company Evaluation Quadrant

10 Profiles of Key Players

  • 10.1 Company A
    • 10.1.1 Business Overview
    • 10.1.2 Product Portfolio
    • 10.1.3 Business Strategies
    • 10.1.4 SWOT Analysis
    • 10.1.5 Major News and Events
  • 10.2 Company B
    • 10.2.1 Business Overview
    • 10.2.2 Product Portfolio
    • 10.2.3 Business Strategies
    • 10.2.4 SWOT Analysis
    • 10.2.5 Major News and Events
  • 10.3 Company C
    • 10.3.1 Business Overview
    • 10.3.2 Product Portfolio
    • 10.3.3 Business Strategies
    • 10.3.4 SWOT Analysis
    • 10.3.5 Major News and Events
  • 10.4 Company D
    • 10.4.1 Business Overview
    • 10.4.2 Product Portfolio
    • 10.4.3 Business Strategies
    • 10.4.4 SWOT Analysis
    • 10.4.5 Major News and Events
  • 10.5 Company E
    • 10.5.1 Business Overview
    • 10.5.2 Product Portfolio
    • 10.5.3 Business Strategies
    • 10.5.4 SWOT Analysis
    • 10.5.5 Major News and Events

11 Japan Clinical Trials Management System Market - Industry Analysis

  • 11.1 Drivers, Restraints, and Opportunities
    • 11.1.1 Overview
    • 11.1.2 Drivers
    • 11.1.3 Restraints
    • 11.1.4 Opportunities
  • 11.2 Porters Five Forces Analysis
    • 11.2.1 Overview
    • 11.2.2 Bargaining Power of Buyers
    • 11.2.3 Bargaining Power of Suppliers
    • 11.2.4 Degree of Competition
    • 11.2.5 Threat of New Entrants
    • 11.2.6 Threat of Substitutes
  • 11.3 Value Chain Analysis

12 Appendix